IL1RL1 and inflammatory bowel disease: Previous studies have shown that IL-33/ST2 signaling is involved in the occurrence and development of various inflammatory and allergic diseases, including rheumatoid arthritis, inflammatory bowel disease, food allergy, and asthma [33–35].